Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Medical+Condition%3A+COVID-19%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22
/vufind/Search/Results?lookfor=%22Medical+Condition%3A+COVID-19%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22
Search /vufind/Search2/Results?lookfor=%22Medical+Condition%3A+COVID-19%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22
PubPharm (230)
1
A study to evaluate an mRNA COVID-19 vaccine (IN002.5.1) in comparison with an approved mRNA COVID-19 vaccine : A randomized, double-blind, active-controlled, phase I clinical study to evaluate the safety, tolerability, and immunogenicity of a COVID-19 mRNA vaccine (in002.5.1) in comparison with an approved mRNA booster vaccine for COVID-19 in population >= 18 years of age
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A study to evaluate an mRNA COVID-19 vaccine (IN002.5.1) in comparison with an approved mRNA COVID-19 vaccine : A randomized, double-blind, active-controlled, phase I clinical study to evaluate the safety, tolerability, and immunogenicity of a COVID-19 mRNA vaccine (in002.5.1) in comparison with an approved mRNA booster vaccine for COVID-19 in population >= 18 years of age
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A study to determine if a new vaccine safely generates good immune responses to protect adults in Kenya from Coronavirus Disease : A phase Ib/II single-blinded, randomised, controlled study to determine safety, immunogenicity and efficacy of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 in adults in Kenya (COV004)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
TANCoV trial : A Multicenter, Phase 1/2a, double-blinded Randomized Controlled non- inferiority Trial to assess Safety and Immunogenicity of TANCoV- 1.3.20 SARS _CoV-2 vaccine in healthy participants in Tanzania
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A Phase I/II Study to Evaluate the Safety, Reactogenicity and Immunogenicity of RBD SARS-CoV-2 HBsAg VLP Vaccine in Healthy Adults. : A Phase I/II Study to Evaluate the Safety, Reactogenicity and Immunogenicity of RBD SARS-CoV-2 HBsAg VLP Vaccine in Healthy Adults.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
ibuprofen in COVID19 : Early use of ibuprofen in COVID-19 might a promising agent to attenuate the severity of the disease: A randomized controlled trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A randomized study, assessing the safety and immunogenicity of a COVID-19 vaccine in healthy adults : A Randomized, Observer-Blind, Dose-Escalation, Placebo-Controlled Phase 1 Clinical Trial of COVAC-1 in Generally Healthy Adults
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Effectiveness of interactive web-based destigmatisation program in reducing stigma among COVID-19 survivors : Effectiveness of interactive web-based destigmatisation program in reducing stigma among COVID-19 survivors; randomised controlled trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A study to determine if a new vaccine safely generates good immune responses to protect adults in Kenya from Coronavirus Disease : A phase Ib/II single-blinded, randomised, controlled study to determine safety, immunogenicity and efficacy of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 in adults in Kenya (COV004)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
TANCoV trial : A Multicenter, Phase 1/2a, double-blinded Randomized Controlled non- inferiority Trial to assess Safety and Immunogenicity of TANCoV- 1.3.20 SARS _CoV-2 vaccine in healthy participants in Tanzania
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 1
Medienart
230
Aufsätze
230
E-Artikel
230
E-Ressourcen
Zeitschriftentitel
150
ClinicalTrials.gov
80
WHO International Clinical Trials Registry Plat...
Thema
230
610
Phase: Phase 1
230
Study Type: Interventional
91
Recruitment Status: Completed
85
COVID-19
62
Medical Condition: COVID-19
46
Recruitment Status: Recruiting
45
Recruitment Status: Not yet recruiting
35
Medical Condition: Covid19
18
Medical Condition: COVID-19; COVID-19;Respirato...
15
Recruitment Status: Withdrawn
13
Recruitment Status: Active, not recruiting
12
Medical Condition: COVID-19; COVID-19;Infection...
10
Recruitment Status: Terminated
9
Coronavirus Infections
7
Pneumonia
6
Acute Lung Injury
6
Medical Condition: COVID-19; COVID-19;Infection...
6
Recruitment Status: Authorised-recruitment may ...
6
Respiratory Distress Syndrome, Newborn
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
28
2023
99
2022
71
2021
32
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
226
Englisch
4
Unbestimmt
Haven't found what you're looking for?
Wird geladen...